Admission to Trading

Summary by AI BETAClose X

GSK plc has announced the admission of 45,273 ordinary shares of 31¼ pence each to trading on the London Stock Exchange's Main Market, bringing the total number of ordinary shares admitted to trading to 4,316,221,551. These shares are fully fungible with existing ordinary shares and were admitted under block listing arrangements related to the GlaxoSmithKline plc Share Save Plan 2022, covering the period from March 27, 2026, to May 22, 2026.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings